Simple Summary Among the top ten deadly solid tumors are the two most frequent liver
cancers, hepatocellular carcinoma, and intrahepatic cholangiocarcinoma, whose …

Alternative splicing produces complex and dynamic changes in the protein isoforms that are
necessary for the proper biological functioning of the metabolic pathways involved in liver …

While changes in RNA splicing have been extensively studied in hepatocellular carcinoma
(HCC), no studies have systematically investigated changes in RNA splicing during earlier …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Serine‐
arginine rich splicing factor 3 (SRSF3) plays a critical role in hepatocyte function and its loss …

Background Hepatocellular carcinoma (HCC) ranks the sixth prevalent tumors with high
mortality globally. Alternative splicing (AS) drives protein diversity, the imbalance of which …

Background Uterine carcinosarcoma (UCS) is an invasive variant of endometrial cancer.
The complicated heterogeneity and low frequency of UCS suggest the relevant research is …

During eukaryotic gene expression, alternative splicing of messenger RNA precursors is
critical in increasing protein diversity and regulatory complexity. Multiple transcript isoforms …

A splicing factor is as an important upstream regulator of the alternative splicing process.
Hence, it is considered to be a therapeutic target for hepatocellular carcinoma (HCC) …

Background Alternative splicing (AS) takes a crucial part in tumor process. We aim to
analyze AS in Hepatitis B virus (HBV) or/and hepatitis C virus (HCV) related hepatocellular …

The worldwide incidence of skin cutaneous melanoma (SKCM) is increasing at a more rapid
rate than other tumors. Aberrant alternative splicing (AS) is found to be common in cancer; …